Firm Analyst
Alliance Global Partners James Molloy
Zacks Small Cap Research David Bautz, PhD

Qualigen Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Qualigen Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Qualigen Therapeutics, Inc. or its management. Qualigen Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.